Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Urology
Volume 2015, Article ID 198381, 4 pages
Case Report

Acute Respiratory Distress Syndrome after Treatment of Metastatic Prostate Cancer with Taxotere: A Case Report and Literature Review

Division of Hematology-Oncology, Department of Medicine, Joan C. Edwards School of Medicine, Marshall University, Edward Comprehensive Care Center, Huntington, WV 25701, USA

Received 23 May 2015; Revised 28 July 2015; Accepted 29 July 2015

Academic Editor: Fumitaka Koga

Copyright © 2015 Ali Raufi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Prostate cancer is the most common cancer in men. Docetaxel is a common chemotherapeutic agent that has proven its efficacy in the treatment of patients with both castration sensitive and resistant metastatic prostate cancer. We report a case of acute respiratory distress syndrome (ARDS) in a patient with metastatic prostate cancer treated with docetaxel (Taxotere). ARDS is very rare but life threatening complication of docetaxel which requires aggressive supportive care and close monitoring. Better awareness and prompt diagnosis of this treatment related ARDS will improve the effectiveness and outcome of its management.